Scott D. Nelson - Concepedia

Author

Scott D. Nelson

University of California, Los Angeles ORCID

Also Known As

Bartosz Chmielowski, Briggs, R J, Charles Forscher, Frederick R. Eilber, Gerald Rosen, J. McCrae, Nelson Scott D., Nelson, Scott, Nelson, Scott D, Nelson, Scott D.

289

Publications

9.1K

Citations

H-Index

142

Concepts

All Affiliations

University of California, Los Angeles University of California San Diego AntiCancer (United States)Yale University Kanazawa University

About

Scott D. Nelson is an author at University of California, Los Angeles specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	47	2.6K
2	Health Sciences	12	14	729
3	Engineering	10	10	466
4	Natural Sciences	1	1	39
5	Nursing	1	1	49

Scott D. Nelson

125

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Histological Features of Pseudotumor-like Tissues From Metal-on-Metal Hips Pat Campbell, Edward Ebramzadeh, Scott D. Nelson, Clinical Orthopaedics and Related Research	2010	548
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone Daniel Branstetter, Scott D. Nelson, J. Carlos Manivel, Clinical Cancer Research	2012	425
Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament Stephen H. Liu, Raad Al‐Shaikh, Vahé Panossian, Journal of Orthopaedic Research® Progesterone Target CellsProgesterone ReceptorsHormonal ReceptorPrimary ImmunolocalizationImmunology	1996	334
Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas Fritz C. Eilber, Gerald Rosen, J J Eckardt, Journal of Clinical Oncology	2001	326
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
High-Grade Extremity Soft Tissue Sarcomas Fritz C. Eilber, Gerald Rosen, Scott D. Nelson, Annals of Surgery	2003	229
Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas Vladimir Evilevitch, Wolfgang Weber, William D. Tap, Clinical Cancer Research	2008	194
Leiomyosarcoma of the inferior vena cava O. Joe Hines, Scott D. Nelson, William J. Quiñones‐Baldrich, Cancer Inferior Vena CavaSurgical OncologyTumoral PathologyMedicineSurgical Pathology	1999	170

Page 1